← back to search

Chiara Dalle Fratte

CS Diagnostics · DE
Area of research
Cancer Research · Gastroenterology
Research interest
Research interests include Cancer Genomics and Diagnostics, Gastrointestinal Tumor Research and Treatment, Lung Cancer Treatments and Mutations, and Colorectal Cancer Treatments and Studies.
h-index
9
citations
336
works
24
NIH funding
primary concept
email

Recent publications

1486 Preliminary results from LuCa-MERIT-1, a phase I trial evaluating BNT116, a fixed antigen mRNA vaccine, plus cemiplimab in advanced non-small cell lung cancer after progression on PD-1 inhibition
2024cited by 9position: middledoi
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA
EBioMedicine 2020cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Erika Cecchin · University of Udine1 papers (2020–2020) · 1 papers (2024–2024)Matthias Schlesner · University of Augsburg1 papers (2020–2020)Marc A. Schneider · Heidelberg University1 papers (2020–2020)Volker Endris · Deutschen Konsortium für Translationale Krebsforschung1 papers (2020–2020) · 1 papers (2024–2024)Uğur Şahin · Technical University of Munich1 papers (2024–2024)Anna‐Lena Volckmar · Heidelberg University1 papers (2020–2020)Steffen Dietz · Deutschen Konsortium für Translationale Krebsforschung1 papers (2020–2020)Thomas Muley · Heidelberg University1 papers (2020–2020)Florian Janke · German Cancer Research Center1 papers (2020–2020) · 1 papers (2024–2024)Michael Thomas · Barwon Health1 papers (2020–2020)Víctor Moreno · Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública1 papers (2024–2024)Patrick T. Bruck · BioNTech (Germany)1 papers (2024–2024)Jürgen Alt · Johannes Gutenberg University Mainz1 papers (2024–2024)David Vicente Baz · Hospital Universitario Virgen Macarena1 papers (2024–2024)Özlem Türeci · Helmholtz Institute for Translational Oncology Mainz1 papers (2024–2024)Michael J. Wenger · BioNTech (Germany)1 papers (2024–2024) · 1 papers (2024–2024)